Piggyback toric IOL effective for astigmatism

Article

Implanting a customized primary or a secondary piggyback toric IOL post-penetrating keratoplasty (PK) is effective for astigmatism, claims a paper in Eye.

Implanting a customized primary or a secondary piggyback toric IOL post-penetrating keratoplasty (PK) is effective for astigmatism, claims a paper in Eye.

Dr S. Srinivasan et al., Department of Ophthalmology, University Hospital Ayr, Ayr, Scotland, UK, conducted a prospective case series on nine eyes of nine patients with post-PK astigmatism.

Of the patients assessed, six underwent simultaneous phacoemulsification (PE) and three pseudophakic eyes received a secondary 'piggyback' toric IOL implanted in the ciliary sulcus. Outcome measures included Pre- and postoperative uncorrected (UDVA) and best-corrected (BDVA) distance visual acuities and refractive errors.

Change in magnitude of astigmatism pre- and postoperatively were calculated by Cartesian astigmatic vectors. Preoperative and postoperative endothelial cell counts were also assessed.

Preoperative UDVA improved from 1.13±0.51 logMAR to 0.48±0.24 postoperatively. BDVA findings did not present any significant changes from 0.31±0.27 to 0.26±0.19. Preoperative and postoperative refractive cylinder was 0.83±1.09 D and 3.89±4.01 D, respectively.

Astigmatic Cartesian x and y coordinates were significantly reduced and mean endothelial cell loss was 9.9%. Both implantation of a customized primary IOL or a secondary piggyback toric IOL were effective modalities for treating patients with high post-PK astigmatism.

To read the abstract please visit the journal here.

Recent Videos
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.